US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Gabapentin USP for prescription compounding

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

What was recalled

Gabapentin USP for prescription compounding, packaged in a) 25g (NDC 58597-8014-4); b) 100g (NDC 58597-8014-6); c) 500g (NDC 58597-8014-7); d) 1000g (NDC 58597-8014-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Recalling firm
American Pharmaceutical Ingredients LLC
NDC code
58597-8014-4
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0494-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Gabapentin recalls

See all
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

The Harvard Drug Group LLC NDC 0904-6665-61 D-0031-2026
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

The Harvard Drug Group LLC NDC 0904-6665-61 D-0030-2026
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Defective container; blister packaging inadequately sealed.

The Harvard Drug Group LLC NDC 55154-3363-0 D-0508-2025
Class II · Moderate risk Ongoing

Gabapentin Capsules

Reason Defective container; blister packaging inadequately sealed.

The Harvard Drug Group LLC NDC 0904-6665-61 D-0507-2025
Class II · Moderate risk Ongoing

Gabapentin Tablets 600mg

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-126-05 D-0320-2025